Clinical parameters correlated with the psoas muscle index in Japanese individuals with type 2 diabetes mellitus

[1]  K. Harada,et al.  Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study , 2022, Investigative and clinical urology.

[2]  Y. Hayashi,et al.  High Protein Diet Feeding Aggravates Hyperaminoacidemia in Mice Deficient in Proglucagon-Derived Peptides , 2022, Nutrients.

[3]  S. Qiu,et al.  MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway , 2021, Diabetologia.

[4]  T. Nishino,et al.  Association between the psoas muscle index and hospitalization for pneumonia in patients undergoing hemodialysis , 2021, BMC Nephrology.

[5]  Y. Bao,et al.  The Nonlinear Relationship Between Psoas Cross-sectional Area and BMI: A New Observation and Its Insights Into Diabetes Remission After Roux-en-Y Gastric Bypass , 2021, Diabetes Care.

[6]  Jing Xu,et al.  Association between muscle mass, bone mineral density and osteoporosis in type 2 diabetes , 2021, Journal of diabetes investigation.

[7]  K. Tabei,et al.  Muscle mass evaluation using psoas muscle mass index by computed tomography imaging in hemodialysis patients. , 2021, Clinical nutrition ESPEN.

[8]  H. Daida,et al.  Low muscle mass assessed by psoas muscle area is associated with clinical adverse events in elderly patients with heart failure , 2021, PloS one.

[9]  Yujing Sun,et al.  β-Cell function is associated with osteosarcopenia in middle-aged and older nonobese patients with type 2 diabetes: A cross-sectional study , 2021, Open medicine.

[10]  S. Iwano,et al.  Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma , 2020, International Journal of Clinical Oncology.

[11]  Y. Hayashi.  Glutaminostatin: Another facet of glucagon as a regulator of plasma amino acid concentrations , 2019, Journal of diabetes investigation.

[12]  F. Hsu,et al.  Psoas and Paraspinous Muscle Measurements on Computed Tomography Predict Mortality in European Americans with Type 2 Diabetes Mellitus , 2019, The Journal of Frailty & Aging.

[13]  Chun-Qiang Lu,et al.  Diabetes risk assessment with imaging: a radiomics study of abdominal CT , 2018, European Radiology.

[14]  J. Divers,et al.  Psoas and paraspinous muscle index as a predictor of mortality in African American men with type 2 diabetes mellitus. , 2018, Journal of diabetes and its complications.

[15]  Frank B. Hu,et al.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications , 2018, Nature Reviews Endocrinology.

[16]  Y. Cho,et al.  Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study. , 2017, Clinical nutrition.

[17]  T. Hawke,et al.  Diabetic Myopathy: current molecular understanding of this novel neuromuscular disorder , 2017, Current opinion in neurology.

[18]  C. Seal,et al.  Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: A case-control study. , 2017, Clinical nutrition.

[19]  K. Park,et al.  Thyroid-stimulating hormone improves insulin sensitivity in skeletal muscle cells via cAMP/PKA/CREB pathway-dependent upregulation of insulin receptor substrate-1 expression , 2016, Molecular and Cellular Endocrinology.

[20]  S. Uemoto,et al.  Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. , 2016, Nutrition.

[21]  J. Terasaki,et al.  Decreased β-Cell Function Is Associated with Reduced Skeletal Muscle Mass in Japanese Subjects without Diabetes , 2016, PloS one.

[22]  L. D. de Groot,et al.  Differences in Nutrient Intake and Biochemical Nutrient Status Between Sarcopenic and Nonsarcopenic Older Adults-Results From the Maastricht Sarcopenia Study. , 2016, Journal of the American Medical Directors Association.

[23]  J. Reginster,et al.  Osteoporosis and sarcopenia: two diseases or one? , 2015, Current opinion in clinical nutrition and metabolic care.

[24]  G. Jerums,et al.  Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise. , 2016, Exercise immunology review.

[25]  Robert R. Henry,et al.  Type 2 diabetes mellitus , 2015, Nature Reviews Disease Primers.

[26]  H. Umegaki.  Sarcopenia and diabetes: Hyperglycemia is a risk factor for age-associated muscle mass and functional reduction , 2015, Journal of diabetes investigation.

[27]  S. Walrand,et al.  Muscle and bone, two interconnected tissues , 2015, Ageing Research Reviews.

[28]  I. Kanazawa,et al.  Reduction in Endogenous Insulin Secretion is a Risk Factor of Sarcopenia in Men with Type 2 Diabetes Mellitus , 2015, Calcified Tissue International.

[29]  G. Brent,et al.  Thyroid hormone regulation of metabolism. , 2014, Physiological reviews.

[30]  J. Eckel,et al.  Myokines in insulin resistance and type 2 diabetes , 2014, Diabetologia.

[31]  M. Cesari,et al.  Sexually dimorphic patterns of nutritional intake and eating behaviors in community-dwelling older adults with normal and slow gait speed , 2014, The journal of nutrition, health & aging.

[32]  J. Terasaki,et al.  Association between skeletal muscle mass and insulin secretion in patients with type 2 diabetes mellitus. , 2014, Endocrine journal.

[33]  K. Park,et al.  Expression of Thyroid Stimulating Hormone Receptor mRNA in Mouse C2C12 Skeletal Muscle Cells , 2013, Endocrinology and metabolism.

[34]  G. Onder,et al.  Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. , 2013, Age and ageing.

[35]  N. Ozaki,et al.  Remodeling of Hepatic Metabolism and Hyperaminoacidemia in Mice Deficient in Proglucagon-Derived Peptides , 2011, Diabetes.

[36]  G. Lippi,et al.  Biochemical markers of muscular damage , 2010, Clinical chemistry and laboratory medicine.

[37]  A. Hevener,et al.  Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III , 2010, PloS one.

[38]  S. Pearce,et al.  Subclinical thyroid disorders: significance and clinical impact , 2010, Journal of Clinical Pathology.

[39]  J. Gregory,et al.  TSH receptor activation and body composition. , 2010, The Journal of endocrinology.

[40]  L. Kuller,et al.  Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes , 2009, Diabetes Care.

[41]  B. Biondi,et al.  The clinical significance of subclinical thyroid dysfunction. , 2008, Endocrine reviews.

[42]  Soroku Yagihashi,et al.  Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms. , 2007, Diabetes research and clinical practice.

[43]  L. Kuller,et al.  Accelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes , 2007, Diabetes Care.

[44]  K. Kaufman,et al.  The impact of overt and subclinical hyperthyroidism on skeletal muscle. , 2006, Thyroid : official journal of the American Thyroid Association.

[45]  S. Costagliola,et al.  Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy , 2005, British Journal of Ophthalmology.

[46]  Sheldon Weinbaum,et al.  Mechanotransduction and strain amplification in osteocyte cell processes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Henning Andersen,et al.  Atrophy of foot muscles: a measure of diabetic neuropathy. , 2004, Diabetes care.

[48]  G. Yancopoulos,et al.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.

[49]  A. Cherrington,et al.  Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. , 1999, Diabetes.

[50]  P. Gadeberg,et al.  Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study , 1997, Diabetologia.

[51]  K. Park,et al.  High 24-Hour Urinary C-Peptide Excretion in Non-Insulin Dependent Diabetes Mellitus* , 1986, The Korean journal of internal medicine.

[52]  K. Offord,et al.  Relationship between bone mineral density of spine and strength of back extensors in healthy postmenopausal women. , 1986, Mayo Clinic proceedings.

[53]  P. Larsen.  Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. , 1975, The Journal of clinical endocrinology and metabolism.